Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Phase 1 Completed
100 enrolled
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Phase 1 Completed
168 enrolled
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
Phase 1 Completed
33 enrolled
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Phase 1 Completed
23 enrolled 21 charts
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Phase 1 Completed
134 enrolled 37 charts
A Study of AL8326 in Healthy Subjects
Phase 1 Completed
6 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Phase 1 Completed
146 enrolled
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Phase 1 Completed
41 enrolled
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
Phase 1 Completed
26 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma
Phase 1 Completed
188 enrolled
CLOVER
Phase 1 Completed
105 enrolled
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled 36 charts
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Phase 1 Completed
60 enrolled
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Phase 1 Completed
23 enrolled
Trial of BMS-986012 in Combination With Platinum and Etoposide
Phase 1 Completed
12 enrolled
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Phase 1 Completed
90 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Phase 1 Completed
12 enrolled 18 charts
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Phase 1 Completed
23 enrolled
Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
Phase 1 Completed
11 enrolled
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
132 enrolled
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
Phase 1 Completed
277 enrolled
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Phase 1 Completed
105 enrolled
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)
Phase 1 Completed
10 enrolled 13 charts
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
22 enrolled
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Phase 1 Completed
48 enrolled
Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours
Phase 1 Completed
92 enrolled
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
DUET-4
Phase 1 Completed
78 enrolled
A Phase Ib/III Clinical Study to Evaluate the Efficacy and Safety of IBI318 in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel in Patients With Small Cell Lung Cancer Who Have Failed First-line or Above Chemotherapies
Phase 1 Completed
20 enrolled
DUET-2
Phase 1 Completed
150 enrolled
A Study of PLX2853 in Advanced Malignancies.
Phase 1 Completed
49 enrolled
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors
Phase 1 Completed
50 enrolled
A Study of SHR-1316 and Fluzoparib(SHR-3162) in Small Cell Lung Cancer Patients
Phase 1 Completed
23 enrolled
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Phase 1 Completed
40 enrolled
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Phase 1 Completed
48 enrolled
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer
Phase 1 Completed
29 enrolled
MK-3475-011
Phase 1 Completed
57 enrolled 60 charts
Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
Phase 1 Completed
20 enrolled
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
Phase 1 Completed
14 enrolled
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Phase 1 Completed
22 enrolled
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled